Literature DB >> 31511617

The upside of stress: a mechanism for the positive motivational role of corticotropin releasing factor.

Julia C Lemos1, Veronica A Alvarez2,3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31511617      PMCID: PMC6879522          DOI: 10.1038/s41386-019-0510-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


× No keyword cloud information.
Intuitively, we know that salient environmental stimuli, even when stressful, can trigger an internal state of urgency that focuses our attention, motivates us to work harder, encourages us to explore new spaces or people, and helps us achieve specific goals. Despite its known benefits, the neural mechanisms that underlie these positive motivational qualities of acute stress remain poorly understood. In the past 10 years, evidence has emerged pointing to a new role for the neuropeptide corticotropin-releasing factor (CRF). CRF is a well-studied stress-associated neuropeptide. A rich literature exists demonstrating neuronal substrates of CRF-evoked energy mobilization, fear, and anxiety. However, when acting in the nucleus accumbens (NAc), CRF has been shown to promote exploratory behaviors and invigoration for reward [1, 2]. Yet, the cellular mechanism(s) mediating these positive motivational actions of CRF in the NAc were not known. In a study published two months ago, we showed that CRF type 1 receptors (CRF-R1) are ubiquitously expressed on cholinergic interneurons within the NAc of adult male mice [3]. We found that CRF produces a robust increase in action potential firing in cholinergic interneurons via CRF-R1 activation and cAMP dependent mechanisms [3]. Cholinergic interneurons form dense axonal ramifications, and therefore, through acetylcholine modulation, can act as master regulators of accumbal output. Previous work had shown that selective ablation of cholinergic interneurons disrupts locomotion and enhanced dopamine transmission triggered by an acute stressor, indicating this cell population plays a critical role in adaptive stress processing [4]. Moreover, work from the Greengard laboratory and others has shown that suppression of cholinergic interneuron firing through a variety of cell-type specific transgenic or chemogenetic manipulations produces behaviors consistent with a depression-like state in mice [5] that is accompanied by a reduction in reward-evoked dopamine release [6]. Thus, we reasoned that the CRF mediated increase of cholinergic interneuron firing may facilitate pathways that drive the opposite behaviors: active coping and hedonic behaviors such as reward consumption. This notion is supported by our original findings that CRF both potentiates dopamine and facilitates appetitive behaviors when acting in the NAc. In this more recent report, we further show that this effect is, in part, due to activation of muscarinic type 5 receptors (M5) on dopamine neuron projections [3]. We propose that CRF’s potentiation of cholinergic and dopaminergic transmission in the NAc is an underlying mechanism for the positive motivational qualities of acute stressors. We further speculate that vulnerabilities to neuropsychiatric diseases such as anxiety, depression, and addiction may develop due to a diminution of the positive qualities of stress, not only an exacerbation of the negative qualities of stress. Studies in human subjects demonstrate disfunction in NAc activity in patients with depression compared to healthy controls in response to positive and negative stimuli using fMRI [7, 8]. Moreover, in mice, Gαs-DREADD activation in accumbal cholinergic interneurons was able to rescue depression-like phenotypes induced by chronic stress [5]. Thus, we remain hopeful that as we expand our understanding of the neuronal substrates that underlie the positive motivational qualities of stress and stress-associated neuropeptides like CRF, we may get closer to understanding the etiology of these diseases and improve treatment.

Funding and disclosure

This study was funded by the Intramural Programs of NIAAA, NINDS (ZIA-AA000421) to VAA, K99/R00 Pathway to Independence award (MH109627) to JCL and 2017 Innovation Award from NIH-DDIR to VAA.
  6 in total

1.  Striatal Cholinergic Interneurons Are a Novel Target of Corticotropin Releasing Factor.

Authors:  Julia C Lemos; Jung Hoon Shin; Veronica A Alvarez
Journal:  J Neurosci       Date:  2019-05-20       Impact factor: 6.167

2.  HCN2 Channels in Cholinergic Interneurons of Nucleus Accumbens Shell Regulate Depressive Behaviors.

Authors:  Jia Cheng; Gali Umschweif; Jenny Leung; Yotam Sagi; Paul Greengard
Journal:  Neuron       Date:  2019-01-10       Impact factor: 17.173

3.  Reduction in cholinergic interneuron density in the nucleus accumbens attenuates local extracellular dopamine release in response to stress or amphetamine.

Authors:  François Laplante; Marc M Dufresne; Jugurtha Ouboudinar; Rafael Ochoa-Sanchez; Ron M Sullivan
Journal:  Synapse       Date:  2012-10-25       Impact factor: 2.562

4.  Striatal Hypersensitivity During Stress in Remitted Individuals with Recurrent Depression.

Authors:  Roee Admon; Laura M Holsen; Harlyn Aizley; Anne Remington; Susan Whitfield-Gabrieli; Jill M Goldstein; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2014-10-02       Impact factor: 13.382

5.  Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder.

Authors:  Diego A Pizzagalli; Avram J Holmes; Daniel G Dillon; Elena L Goetz; Jeffrey L Birk; Ryan Bogdan; Darin D Dougherty; Dan V Iosifescu; Scott L Rauch; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2009-05-01       Impact factor: 18.112

6.  Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive.

Authors:  Julia C Lemos; Matthew J Wanat; Jeffrey S Smith; Beverly A S Reyes; Nick G Hollon; Elisabeth J Van Bockstaele; Charles Chavkin; Paul E M Phillips
Journal:  Nature       Date:  2012-09-19       Impact factor: 49.962

  6 in total
  3 in total

1.  Corticotropin releasing factor (CRF) systems: Promoting cocaine pursuit without distress via incentive motivation.

Authors:  Hannah M Baumgartner; Madeliene Granillo; Jay Schulkin; Kent C Berridge
Journal:  PLoS One       Date:  2022-05-03       Impact factor: 3.752

2.  Activating Corticotropin-Releasing Factor Systems in the Nucleus Accumbens, Amygdala, and Bed Nucleus of Stria Terminalis: Incentive Motivation or Aversive Motivation?

Authors:  Hannah M Baumgartner; Jay Schulkin; Kent C Berridge
Journal:  Biol Psychiatry       Date:  2021-01-21       Impact factor: 12.810

3.  Opposite effects of stress on effortful motivation in high and low anxiety are mediated by CRHR1 in the VTA.

Authors:  Ioannis Zalachoras; Simone Astori; Mandy Meijer; Jocelyn Grosse; Olivia Zanoletti; Isabelle Guillot de Suduiraut; Jan M Deussing; Carmen Sandi
Journal:  Sci Adv       Date:  2022-03-23       Impact factor: 14.136

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.